CASE REPORT: SEQUENTIAL COMBINATION TARGETED THERAPY WITH TYPE I AND II MET INHIBITORS IN A METASTATIC EGFR-MUTATED, MET-AMPLIFIED NSCLC PATIENT WITH ACQUIRED MET Y1230H MUTATION

Case Report: Sequential Combination Targeted Therapy With Type I and II MET Inhibitors in a Metastatic EGFR-Mutated, MET-Amplified NSCLC Patient With Acquired MET Y1230H Mutation

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the standard of care for advanced non-small-cell lung envox stock cancer (NSCLC) patients.However, most patients will eventually develop resistance.For EGFR-TKI resistance mediated by MET amplification, the combination of EGFR and MET TKIs has shown promising results in e

read more

The Greco-Roman Rhetoric Background of Sophia in 1 Corinthians 1-4

It seems that the Corinthians appreciated lexus rc4 rhetorical eloquence and had therefore esteemed their teachers according to their rhetorical abilities.This could be the root problem behind dissensions as they are confronted by the apostle Paul in 1 Corinthians 1-4.This hypothesis is one among other proposals for the background behind the concep

read more